USPSTF: Screening Kids for Lipid Disorders Still Needs More Data
For the third time in 15 years, the task force has given an “I” recommendation to screening, citing not enough research.
Related Articles
After DanGer Shock’s Win in AMICS for Impella: What’s Next?
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Statins Might Help in HFpEF—Even in the Absence of ASCVD
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
The SELECT Trial
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.
Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift
ULTIMATE-DAPT seemed to indicate the safety and efficacy of this strategy, but it hasn’t seemed to shift practice, yet.
TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites
Just one in nine US centers had similar short-term outcomes with TAVI and M-TEER, say researchers.
As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes
Operators predict a shift in how they’ll treat in-stent restenosis, and maybe more, in coming years.
TCTMD’s Top 10 Most Popular Stories for April 2024
All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.
TCTMD’s Top 10 Most Popular Stories for April 2024
All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.